Chimeric recombinant human metapneumoviruses with the nucleoprotein or phosphoprotein open reading frame replaced by that of avian metapneumovirus exhibit improved growth in vitro and attenuation in vivo - Wikidata - awgldk - TriplyDB

Chimeric recombinant human metapneumoviruses with the nucleoprotein or phosphoprotein open reading frame replaced by that of avian metapneumovirus exhibit improved growth in vitro and attenuation in vivo

Chimeric recombinant human metapneumoviruses with the nucleoprotein or phosphoprotein open reading frame replaced by that of avian metapneumovirus exhibit improved growth in vitro and attenuation in vivo

http://www.wikidata.org/entity/Q34228628

about

Human metapneumovirus M2-2 protein inhibits innate cellular signaling by targeting MAVS Human Metapneumovirus: lessons learned over the first decade Recent vaccine development for human metapneumovirus Rational design of human metapneumovirus live attenuated vaccine candidates by inhibiting viral mRNA cap methyltransferase Recovery of avian metapneumovirus subgroup C from cDNA: cross-recognition of avian and human metapneumovirus support proteins.Nonsegmented negative-strand viruses as vaccine vectors.Molecular comparisons of full length metapneumovirus (MPV) genomes, including newly determined French AMPV-C and -D isolates, further supports possible subclassification within the MPV Genus.Frequent frameshift and point mutations in the SH gene of human metapneumovirus passaged in vitro.Lung CD8+ T Cell Impairment Occurs during Human Metapneumovirus Infection despite Virus-Like Particle Induction of Functional CD8+ T Cells.Epidemiology of human metapneumovirus.Live vaccines for human metapneumovirus designed by reverse genetics.The large polymerase protein is associated with the virulence of Newcastle disease virus.A live attenuated human metapneumovirus vaccine strain provides complete protection against homologous viral infection and cross-protection against heterologous viral infection in BALB/c mice.Recent developments with live-attenuated recombinant paramyxovirus vaccines.RNA-based viral vectors.New Approaches for Immunization and Therapy against Human Metapneumovirus Modulation of Host Immunity by the Human Metapneumovirus.Aberrant T cell immunity triggered by human Respiratory Syncytial Virus and human Metapneumovirus infection.Current developments and prospects on human metapneumovirus vaccines.Evaluation of a Live Attenuated Human Metapneumovirus Vaccine in Adults and Children.Systematic annotation and analysis of "virmugens"-virulence factors whose mutants can be used as live attenuated vaccines.Human metapneumovirus - what we know now.Progress in respiratory virus vaccine development

P2860

Q24299636-078CA903-C78C-426F-8FFA-FC35C8BE07F9 Q26822938-CA96111C-82E4-447F-AC29-26CBD91D2205 Q27023742-7864C617-0128-4968-9F4A-B7190CCC580E Q34261898-2A85555B-BA9F-4ED1-B37E-70AB53624258 Q34651310-5AD15921-35D8-4E95-BCA0-C5724D8AF72E Q35139219-99DCE9D0-32B3-4200-BF48-F690E4CDE331 Q35208775-A9C8CD85-438F-4ECC-9DA3-431281C4304E Q35857720-506E8984-8DBD-45E4-AA14-85CC8484C607 Q35913925-95EA8654-9D80-4D05-93B1-A5D352B333D1 Q36538868-D46A80A0-5A60-4646-BAE0-2310AF74D405 Q36689031-329463D6-EE3E-473D-9374-5A8956AA2ADB Q36845605-B6B6208E-2A12-442F-81B6-CFA16B766F6C Q37124759-6724F27D-237F-4143-9EDA-3546D6B5FB98 Q38008607-0306C193-BFF5-498F-90F1-AEC4628A5B3D Q38266413-25B36820-C4E3-4D9F-80E7-7E3D76F71813 Q38524373-8B82B1D7-108C-4899-8BCB-6822D6F8EF85 Q38896046-B258A483-9D2F-4B38-AB54-34CB196AF1E5 Q39027049-DF98DF55-E260-4C69-830D-C7DC5F221CB6 Q39100302-37795B30-76CE-4A2F-AF91-C3B080768E1C Q40227524-D03190AA-DA8B-4D70-B631-437856EC1EA4 Q41830548-5E8801B1-8E1B-4E87-AF41-307D40E67DA2 Q55012068-BBFC6354-A8BC-4213-9F06-AE78E4DE2056 Q56894869-02148027-3AD2-47CE-9723-001FA79B4522

P2860

Chimeric recombinant human metapneumoviruses with the nucleoprotein or phosphoprotein open reading frame replaced by that of avian metapneumovirus exhibit improved growth in vitro and attenuation in vivo

http://www.wikidata.org/entity/Q34228628

description

2005 nî lūn-bûn

@nan

2005 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Chimeric recombinant human met ...... vitro and attenuation in vivo

@ast

Chimeric recombinant human met ...... vitro and attenuation in vivo

@en

Chimeric recombinant human met ...... vitro and attenuation in vivo

@nl

type

label

Chimeric recombinant human met ...... vitro and attenuation in vivo

@ast

Chimeric recombinant human met ...... vitro and attenuation in vivo

@en

Chimeric recombinant human met ...... vitro and attenuation in vivo

@nl

prefLabel

Chimeric recombinant human met ...... vitro and attenuation in vivo

@ast

Chimeric recombinant human met ...... vitro and attenuation in vivo

@en

Chimeric recombinant human met ...... vitro and attenuation in vivo

@nl

P1433

Q34228628-9146EC06-9961-4DBF-AF68-34E1588AC2B6

P1476

Q34228628-22870395-14D6-412A-BA59-60537EC62B3D

P2093

Q34228628-194D379B-90FC-4BF3-89FE-B80F68F528DB

Q34228628-29301CA3-7E50-4965-85E3-BE67DEAE21EA

Q34228628-7C169FA3-DCA4-43C9-9E9A-857ED707AC3C

Q34228628-87531F08-9918-4B13-8365-70B5AB777EB8

Q34228628-DADED563-CAFF-40A9-BB2C-92843AAC8CF7

Q34228628-E6A35C3B-33B8-41A1-92C2-B1B96FFAE232

P2860

Q34228628-01CC6D6D-426A-4B5E-9699-482CA4FE58A4

Q34228628-08E18622-8C24-46F3-A20A-0E97A8E0DF1F

Q34228628-20B5C434-C239-4A70-A236-D8A3B0945157

Q34228628-23186F2E-89B4-4398-84BE-D9CE820776A1

Q34228628-2968F96B-7C64-40F4-9FFE-FE6FA2E29285

Q34228628-30561816-9433-4DB2-8D49-6849C71A9BB5

Q34228628-30852D4B-4561-4DE0-82A1-28E5E395B8FF

Q34228628-379C366E-60B6-46B8-BC57-55672093E431

Q34228628-3AD86C7B-DFB3-435F-98E2-40B6EEEAD2B5

Q34228628-3ADFEB1A-A794-498F-B2B7-D5FCEC40658B

P304

Q34228628-F7437D75-5D04-4B4B-89DE-95B7E51884A0

P31

Q34228628-2572A8B9-E7E7-42D9-A0BD-BE246CF69C43

P356

Q34228628-96D1565B-161A-4456-815B-5847830A506E

P407

Q34228628-A63FF60A-F321-44B5-83A3-90E76D4BA798

P433

Q34228628-4689BFB8-E345-4CC4-87F5-17746058A2DD

P478

Q34228628-E3799D8A-CFAA-450A-82B1-F18870576353

P577

Q34228628-D8C5C8B2-7211-457D-9F93-D0E66B76D679

P5875

Q34228628-0EC8FF18-887F-4E4B-B8B0-AE2203AE48DC

P698

Q34228628-FD5A70FD-4709-4C4F-AA56-447B33A74EB9

P932

Q34228628-FD997FF8-F1B1-40AD-B6A7-F0ED7786C543

P356

JVI.79.24.15114-15122.2005

P1433

Journal of Virology

P1476

Chimeric recombinant human met ...... vitro and attenuation in vivo

@en

P2093

Brian R Murphy

http://www.w3.org/2001/XMLSchema#string

Mario H Skiadopoulos

http://www.w3.org/2001/XMLSchema#string

Peter L Collins

http://www.w3.org/2001/XMLSchema#string

Quynh N Pham

http://www.w3.org/2001/XMLSchema#string

Stéphane Biacchesi

http://www.w3.org/2001/XMLSchema#string

Ursula J Buchholz

http://www.w3.org/2001/XMLSchema#string

P2860

Bovine parainfluenza virus type 3 (BPIV3) fusion and hemagglutinin-neuraminidase glycoproteins make an important contribution to the restricted replication of BPIV3 in primates.

Comparison of the transcription and replication strategies of marburg virus and Ebola virus by using artificial replication systems

Deletion of M2 gene open reading frames 1 and 2 of human metapneumovirus: effects on RNA synthesis, attenuation, and immunogenicity

Chimeric bovine respiratory syncytial virus with glycoprotein gene substitutions from human respiratory syncytial virus (HRSV): effects on host range and evaluation as a live-attenuated HRSV vaccine

A recombinant human parainfluenza virus type 3 (PIV3) in which the nucleocapsid N protein has been replaced by that of bovine PIV3 is attenuated in primates.

A newly discovered human pneumovirus isolated from young children with respiratory tract disease.

A chimeric human-bovine parainfluenza virus type 3 expressing measles virus hemagglutinin is attenuated for replication but is still immunogenic in rhesus monkeys.

Infection of nonhuman primates with recombinant human metapneumovirus lacking the SH, G, or M2-2 protein categorizes each as a nonessential accessory protein and identifies vaccine candidates

Analysis of the genomic sequence of a human metapneumovirus.

The two major human metapneumovirus genetic lineages are highly related antigenically, and the fusion (F) protein is a major contributor to this antigenic relatedness

P304

15114-15122

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.79.24.15114-15122.2005

http://www.w3.org/2001/XMLSchema#string

P407

P433

24

http://www.w3.org/2001/XMLSchema#string

P478

79

http://www.w3.org/2001/XMLSchema#string

P577

2005-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7461504

http://www.w3.org/2001/XMLSchema#string

P698

16306583

http://www.w3.org/2001/XMLSchema#string

P932

1316028

http://www.w3.org/2001/XMLSchema#string